Kara Gibson

Kara Gibson, PhD, is currently the Global Scientific Director at Roche. They previously held positions at Eli Lilly and Company as a PhD student and served as a Global Medical Director at Roche in 2021. Kara has extensive experience in neuropsychopharmacology, having worked as a Medical Scientific Liaison and Health Economics & Outcomes Research Manager at Novartis from 2013 to 2016. They also contributed to the European College of Neuropsychopharmacology (ECNP) as an adviser and were a research assistant at both the University of St Andrews and the University of Dundee, where they completed their PhD. Kara earned an MSc in Health Economics from the University of York with distinction and holds a BSc in Cell Biology from the University of St Andrews.